➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Colorcon
McKesson
AstraZeneca
Merck

Last Updated: January 25, 2021

DrugPatentWatch Database Preview

Caffeine citrate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for caffeine citrate and what is the scope of patent protection?

Caffeine citrate is the generic ingredient in two branded drugs marketed by Hikma, Am Regent, Aurobindo Pharma Ltd, Exela Pharma Science, Fresenius Kabi Usa, Micro Labs, Sagent Pharms, Sun Pharm, and Exela Pharma, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for caffeine citrate. Eight suppliers are listed for this compound.

Drug Prices for caffeine citrate

See drug prices for caffeine citrate

Recent Clinical Trials for caffeine citrate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Medical University of WarsawPhase 1
University of FlorenceN/A
Ain Shams UniversityPhase 3

See all caffeine citrate clinical trials

Pharmacology for caffeine citrate
Medical Subject Heading (MeSH) Categories for caffeine citrate

US Patents and Regulatory Information for caffeine citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa CAFFEINE CITRATE caffeine citrate SOLUTION;INTRAVENOUS 077997-001 Jul 20, 2007 AP RX No No   Start Trial   Start Trial   Start Trial
Exela Pharma CAFFEINE CITRATE caffeine citrate SOLUTION;ORAL 077304-001 Sep 21, 2006 AA RX No No   Start Trial   Start Trial   Start Trial
Hikma CAFCIT caffeine citrate SOLUTION;INTRAVENOUS 020793-001 Sep 21, 1999 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Sun Pharm CAFFEINE CITRATE caffeine citrate SOLUTION;INTRAVENOUS 090077-001 Sep 30, 2009 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm CAFFEINE CITRATE caffeine citrate SOLUTION;ORAL 090357-001 Sep 30, 2009 AA RX No No   Start Trial   Start Trial   Start Trial
Sagent Pharms CAFFEINE CITRATE caffeine citrate SOLUTION;ORAL 091102-001 Aug 29, 2012 AA RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Moodys
Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.